| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 12 |
| 1 | DEXAMETHASONE 1.5 MG | 12 |
| 2 | CYCLOPHOSPHAMIDE | 10 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 5 | AMPHOTERICIN B | 5 |
| 6 | CYTARABINE | 4 |
| 7 | ETOPOSIDE | 4 |
| 8 | FLUDARABINE PHOSPHATE | 4 |
| 9 | IFOSFAMIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN BOTULINUM NEUROTOXIN A/B IMMUNE GLOBULIN | 1 | 0.0244 |
| 1 | ECHINACEA (ANGUSTIFOLIA), TABEBUIA IMPETIGINOSA, HYDRASTIS CANADENSIS, GLANDULA SUPRARENALIS SUIS, THYMUS (SUIS), THYROIDINUM (SUIS), ARSENICUM ALBUM, BRYONIA (ALBA), COCCULUS INDICUS, COLCHICUM AUTUMNALE, LEDUM PALUSTRE, MERCURIUS CYANATUS, NATRUM SULPHURICUM, PULSATILLA (PRATENSIS), SEPIA, SILICEA, AFLATOXIN (B1) | 1 | 0.0014 |
| 2 | DINUTUXIMAB | 1 | 0.0012 |
| 3 | SMOFLIPID | 1 | 0.0011 |
| 4 | PYRIMETHAMINE | 1 | 0.0008 |
| 5 | CHLORAMBUCIL | 3 | 0.0008 |
| 6 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 7 | THIOGUANINE | 1 | 0.0005 |
| 8 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 9 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 4 | 0.0001 |